0000899243-22-014358.txt : 20220408 0000899243-22-014358.hdr.sgml : 20220408 20220408163024 ACCESSION NUMBER: 0000899243-22-014358 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220329 FILED AS OF DATE: 20220408 DATE AS OF CHANGE: 20220408 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Deniger Drew CENTRAL INDEX KEY: 0001921961 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33038 FILM NUMBER: 22817397 MAIL ADDRESS: STREET 1: C/O ALAUNOS THERAPEUTICS, INC. STREET 2: 8030 EL RIO ST. CITY: HOUSTON STATE: TX ZIP: 77054 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alaunos Therapeutics, Inc. CENTRAL INDEX KEY: 0001107421 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 841475642 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8030 EL RIO STREET CITY: HOUSTON STATE: TX ZIP: 77054 BUSINESS PHONE: (346) 355-4099 MAIL ADDRESS: STREET 1: 8030 EL RIO STREET CITY: HOUSTON STATE: TX ZIP: 77054 FORMER COMPANY: FORMER CONFORMED NAME: ZIOPHARM ONCOLOGY INC DATE OF NAME CHANGE: 20050919 FORMER COMPANY: FORMER CONFORMED NAME: EASYWEB INC DATE OF NAME CHANGE: 20010213 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2022-03-29 0 0001107421 Alaunos Therapeutics, Inc. TCRT 0001921961 Deniger Drew C/O ALAUNOS THERAPEUTICS, INC. 8030 EL RIO ST. HOUSTON TX 77054 0 1 0 0 VP, Research & Development Common Stock 15000 D Employee Stock Option (right to buy) 4.13 2029-09-23 Common Stock 50000 D Employee Stock Option (right to buy) 4.72 2029-12-30 Common Stock 30000 D Employee Stock Option (right to buy) 2.82 2031-01-03 Common Stock 75000 D Employee Stock Option (right to buy) 4.31 2031-03-03 Common Stock 35000 D Employee Stock Option (right to buy) 1.50 2031-10-28 Common Stock 250000 D The option was granted on September 24, 2019. One-fourth of the shares underlying the option vested on September 24, 2020, and the remainder vests in twelve successive equal quarterly installments measured from September 24, 2020, subject to the Reporting Person's continued service through each such date. The option was granted on December 31, 2019. One-twelfth of the shares underlying the option vest in equal quarterly installments commencing three months after the grant date, subject to the Reporting Person's continued service through each such date. The option was granted on January 4, 2021. One-twelfth of the shares underlying the option vest in equal quarterly installments commencing three months after the grant date, subject to the Reporting Person's continued service through each such date. The option was granted on March 4, 2021. One-sixteenth of the shares underlying the option vest in equal quarterly installments commencing three months after December 31, 2020, subject to the Reporting Person's continued service through each such date. The option was granted on October 29, 2021. One-sixteenth of the shares underlying the option vest in equal quarterly installments commencing three months after the grant date, subject to the Reporting Person's continued service through each such date. /s/ Drew Deniger 2022-04-08